Registration number:
Histopathological Plus Limited
for the Year Ended 30 September 2024
Histopathological Plus Limited
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Histopathological Plus Limited
Company Information
|
Director |
Dr S Neda |
|
Registered office |
|
|
Accountants |
|
Histopathological Plus Limited
(Registration number: 12902161)
Balance Sheet as at 30 September 2024
|
2024 |
2023 |
|
|
Fixed assets |
|
- |
|
Current assets |
|
|
|
Prepayments and accrued income |
- |
( |
|
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Accruals and deferred income |
( |
( |
|
|
|
|
|
Capital and reserves |
|
|
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
|
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
|
Related party transactions |
|
Transactions with the director |
|
2024 |
At 1 October 2023 |
Advances to director |
Repayments by director |
At 30 September 2024 |
|
Dr S Neda |
||||
|
|
- |
( |
|
|
For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Histopathological Plus Limited
(Registration number: 12902161)
Balance Sheet as at 30 September 2024
Director's responsibilities:
|
• |
|
|
• |
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
|
......................................... |